Use Of Aminopyridine, In Particular Amirampridine, In The Treatment Of Virally Associated Fatigue
Patent No. EP4349333 (titled "Use Of Aminopyridine, In Particular Amirampridine, In The Treatment Of Virally Associated Fatigue") was filed by Bhmeke on Jul 28, 2023. The application was issued on Oct 30, 2024.
Patent Summary
Patent Family
Patent Oppositions
Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.
Dossier Documents
The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.
Date
Description
Get instant alerts for new documents
EP4349333
- Application Number
- EP23188553A
- Filing Date
- Jul 28, 2023
- Status
- Granted And Under Opposition
- Sep 27, 2024
- Publication Date
- Oct 30, 2024
- External Links
- Slate, EP4349333B1, Google Patents